Biolase, Inc.
BIOL
BIOL was delisted on the 18th of June, 2024.
39 hedge funds and large institutions have $40M invested in Biolase, Inc. in 2013 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 8 closing their positions.
83% more capital invested
Capital invested by funds: $21.9M → $40M (+$18.1M)
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
11% less funds holding
Funds holding: 44 → 39 (-5)
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$6.59M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$356K |
| 3 |
MCM
Murphy Capital Management
Bedminster,
New Jersey
|
+$71.1K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$47.4K |
| 5 |
OC
Oppenheimer & Co
New York
|
+$47.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
-$837K |
| 2 |
PPSG
Princeton Portfolio Strategies Group
Princeton,
New Jersey
|
-$237K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$219K |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$213K |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$119K |
BIOL Hedge Fund Activity: Q4 2013 in Review
39 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q4 2013, worth a combined $40M — up 83% from $21.9M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of BIOL and 4 opened new positions — a net loss of 4 holders — while 9 trimmed existing stakes and 8 added.
The largest buyer was Oracle Investment Management, adding an estimated $6.59M. The largest seller was THB Asset Management, exiting entirely with an estimated $837K sold.
- 39 institutional investors held Biolase, Inc. (BIOL) as of Q4 2013, down from 44 in Q3 2013.
- Funds reported $40M of Biolase, Inc. stock for Q4 2013, up 83% quarter-over-quarter.
- 4 funds opened new Biolase, Inc. positions in Q4 2013 and 8 closed out, a net change of -4 holders.
- The largest Biolase, Inc. buyer in Q4 2013 was Oracle Investment Management, an estimated $6.59M added.
- The largest Biolase, Inc. seller in Q4 2013 was THB Asset Management, an estimated $837K sold.
Based on aggregated 13F filings for Q4 2013.